Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Financings in Brief: Marquette Medical Systems

This article was originally published in The Gray Sheet

Executive Summary

Marquette Medical Systems: Shareholder rights plan approved by the firm's board would become effective if a person or group acquired 20% or more of the firm's outstanding stock, Marquette says. Marquette notes it will issue 262,500 shares of its class A common stock to its chairman, Michael Cuhady, in exchange for Cuhady's 26.3 mil. shares of class C common. The move, which will be completed Dec. 23, will make Marquette's class A shares the only class of stock outstanding...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT007295

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel